Dr Mitchell Stark
UQ Amplify Researcher
Frazer Institute
Course Coordinator, Skin Cancer
General Practice Clinical Unit
Affiliate Senior Research Fellow
Institute for Molecular Bioscience
+61 7 344 38027
Dr Mitchell Stark leads the Skin cancer genomics and biomarker discovery group.
Researcher biography
Dr Mitchell Stark is a molecular biologist and Group Leader/Senior Research Fellow from the Dermatology Research Centre (DRC) based at the Frazer Institute. His group has extensive experience in microRNA biology and biomarker discovery, next-generation sequencing, bioinformatics, and functional analysis for a variety of applications. The Stark Lab's major research streams include: miRNA biomarkers for melanoma progression and the development a Genomics Atlas of pre-skin cancer lesions, which aim to provide insight into the early progression of melanoma and keratinocyte cancer, to aid in preventing invasive skin cancer formation and offer increased precision to the clinical management of patients.
Dr Stark completed his PhD (2015) in melanoma microRNA biomarkers at The Queensland University of Technology based at the QIMR Berghofer (QIMRB) Medical Research Institute. Prior to commencing his PhD, he worked as Senior Research Assistant (since 1999) and was trained and mentored in the Hayward lab (QIMRB) where he contributed to and led some seminal findings in the melanoma genetics/genomics field. Dr Stark joined the DRC in 2015 and in 2016 he was awarded a prestigious NHMRC Peter Doherty Early Career Fellowship to lead a pre-melanoma genomics program. Dr Stark has a career total of 80+ publications (h-index 35) including 1 patent and has published in respected journals such as Nature, Nature Genetics, Cancer Research, and Journal of Investigative Dermatology.
Book Chapter
Stark, Mitchell S. and Bonazzi, Vanessa F. (2017). Gene expression array analysis to identify candidate tumor suppressor genes in melanoma. Methods in Molecular Biology. (pp. 1-17) New York, NY, United States: Springer. doi: 10.1007/7651_2017_54
Journal Articles
Sturm, Richard A., Smit, Darren J., Duffy, David L., McLean, Catriona, Scolyer, Richard A., McArthur, Grant A., Papenfuss, Anthony T., Stark, Mitchell S., Soyer, H. Peter and Mar, Victoria J. (2024). Uncovering molecular mechanisms for amelanotic/hypopigmented primary cutaneous melanoma. British Journal of Dermatology ljae336. doi: 10.1093/bjd/ljae336
Kao, Yung-Ching and Stark, Mitchell S (2024). Challenging the lymph node progression model of melanoma. The Journal of Investigative Dermatology, 144 (11), 2344-2346. doi: 10.1016/j.jid.2024.04.021
Maas, Ellie J., DeBortoli, Emily, Nathan, Vaishnavi, Freeman, Ned P., Mothershaw, Adam, Smit, Darren J., Betz-Stablein, Brigid, Aoude, Lauren G., Stark, Mitchell S., Sturm, Richard A., Soyer, H. Peter and McInerney-Leo, Aideen M. (2024). POT1 and multiple primary melanomas: the dermatological phenotype. Journal of Medical Genetics, 61 (9) jmg-2023-109637, 1-4. doi: 10.1136/jmg-2023-109637
Hossain, Akbor, Tom, Lisa N., Melati‐Rad, Ala, Yamada, Miko, Hammerlindl, Sabrina, Jagirdar, Kasturee, Prow, Tarl W., Soyer, H. Peter and Stark, Mitchell S. (2024). MicroRNA expression profiling of cutaneous squamous cell carcinomas and precursor lesions. Skin Health and Disease, 4 (3) e360, e360. doi: 10.1002/ski2.360
Qi, X., Bertling, K., Torniainen, J., Kong, F., Gillespie, T., Primiero, C., Stark, M. S., Dean, P., Indjin, D., Li, L. H., Linfield, E. H., Davies, A. G., Brünig, M., Mills, T., Rosendahl, C., Soyer, H. P. and Rakić, A. D. (2024). Terahertz in vivo imaging of human skin: toward detection of abnormal skin pathologies. APL Bioengineering, 8 (1) 016117, 016117. doi: 10.1063/5.0190573
Stark, Mitchell S., Sturm, Richard A., Pan, Yan, Smit, Darren J., Kommajosyula, Varsha, Lee, Katie J., Jagirdar, Kasturee, McLean, Catriona, Duffy, David L., Soyer, H. Peter and Mar, Victoria J. (2024). Assessing the genetic risk of nodular melanoma using a candidate gene approach. British Journal of Dermatology, 190 (2), 199-206. doi: 10.1093/bjd/ljad365
Lee, Katie J., Soyer, H. Peter and Stark, Mitchell S. (2023). The skin molecular ecosystem holds the key to nevogenesis and melanomagenesis. The Journal of Investigative Dermatology, 144 (3), 456-465. doi: 10.1016/j.jid.2023.09.271
Stark, Mitchell S., Harris, Teresa, Grossman, Douglas and Judson-Torres, Robert (2023). BRAF variant allele fraction-A predictor of response to targeted therapy?. Journal of the European Academy of Dermatology and Venereology., 37 (10), 1945-1946. doi: 10.1111/jdv.19389
Vergara, Ismael A. and Stark, Mitchell S. (2023). One step closer to improving melanoma diagnosis and prognosis with liquid biopsies. British Journal of Dermatology, 189 (3) ARTN ljad185, 255-256. doi: 10.1093/bjd/ljad185
Maas, Ellie J., Wallingford, Courtney K., DeBortoli, Emily, Smit, Darren J., Betz-Stablein, Brigid, Aoude, Lauren G., Stark, Mitchell S., Sturm, Richard A., Soyer, H. Peter and McInerney-Leo, Aideen M. (2023). GOLM1: expanding our understanding of melanoma susceptibility. Journal of Medical Genetics, 60 (9) jmg-2023-109348, 1-3. doi: 10.1136/jmg-2023-109348
Jayasinghe, Dilki, Betz-Stablein, Brigid, Stark, Mitchell S., Soyer, H. Peter and Janda, Monika (2023). Spatial Randomness in the distribution of acquired melanocytic naevi of the back in a population-based sample. The Journal of Investigative Dermatology, 143 (6), 1108-1111.e3. doi: 10.1016/j.jid.2022.11.013
Muse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. Journal of Investigative Dermatology, 143 (9), 1830-1834. doi: 10.1016/j.jid.2023.03.1653
Qi, Xiaoqiong, Bertling, Karl, Stark, Mitchell S., Taimre, Thomas, Kao, Yung-Ching, Lim, Yah Leng, Han, She, O'Brien, Blake, Collins, Angus, Walsh, Michael, Torniainen, Jari, Gillespie, Timothy, Donose, Bogdan C., Dean, Paul, Li, Lian He, Linfield, Edmund H., Davies, A. Giles, Indjin, Dragan, Soyer, H. Peter and Rakic, Aleksandar D. (2023). Terahertz imaging of human skin pathologies using laser feedback interferometry with quantum cascade lasers. Biomedical Optics Express, 14 (4) ARTN 480615, 1393-1410. doi: 10.1364/boe.480615
Stark, Mitchell S. (2023). Deficiencies in mismatch DNA repair: providing the soil for large-to-giant congenital melanocytic naevus development. The British journal of dermatology, 188 (1) ARTN ljac037, 5-5. doi: 10.1093/bjd/ljac037
Muse, Meghan E., Bergman, Drew T., Salas, Lucas A., Tom, Lisa N., Tan, Jean-Marie, Laino, Antonia, Lambie, Duncan, Sturm, Richard A., Schaider, Helmut, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2022). Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi. The Journal of Investigative Dermatology, 142 (7), 1893-1902.e7. doi: 10.1016/j.jid.2021.11.025
Huang, Nancy, Lee, Katie J. and Stark, Mitchell S. (2022). Current trends in circulating biomarkers for melanoma detection. Frontiers in Medicine, 9 873728, 873728. doi: 10.3389/fmed.2022.873728
Lee, Katie J. and Stark, Mitchell S. (2022). In Vivo Melanoma Cell Morphology and Tumor Aggressiveness: The Promise of Reflectance Confocal Microscopy in Reducing Unnecessary Excisions. Journal of Investigative Dermatology, 142 (8), 2053-2054. doi: 10.1016/j.jid.2022.01.011
Lee, Katie J., Betz-Stablein, Brigid, Stark, Mitchell S., Janda, Monika, McInerney-Leo, Aideen M., Caffery, Liam J., Gillespie, Nicole, Yanes, Tatiane and Soyer, H. Peter (2022). The future of precision prevention for advanced melanoma. Frontiers in Medicine, 8 818096, 818096. doi: 10.3389/fmed.2021.818096
Wang, Jing, Kao, Yung‐Ching, Zhou, Quan, Wuethrich, Alain, Stark, Mitchell S., Schaider, Helmut, Soyer, H. Peter, Lin, Lynlee L. and Trau, Matt (2021). An integrated microfluidic‐SERS platform enables sensitive phenotyping of serum extracellular vesicles in early stage melanomas. Advanced Functional Materials, 32 (3) 2010296, 1-9. doi: 10.1002/adfm.202010296
Giblin, William, Bringman-Rodenbarger, Lauren, Guo, Angela H., Kumar, Surinder, Monovich, Alexander C., Mostafa, Ahmed M., Skinner, Mary E., Azar, Michelle, Mady, Ahmed S.A., Chung, Carolina H., Kadambi, Namrata, Melong, Keith-Allen, Lee, Ho-Joon, Zhang, Li, Sajjakulnukit, Peter, Trefely, Sophie, Varner, Erika L., Iyer, Sowmya, Wang, Min, Wilmott, James S., Soyer, H. Peter, Sturm, Richard A., Pritchard, Antonia L., Andea, Aleodor A., Scolyer, Richard A., Stark, Mitchell S., Scott, David A., Fullen, Douglas R., Bosenberg, Marcus W. ... Lombard, David B. (2021). The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics. Journal of Clinical Investigation, 131 (12) e138926, 1-19. doi: 10.1172/jci138926
Kan, Chin Fung Kelvin, Unis, Graham D., Li, Luke Z., Gunn, Susan, Li, Li, Soyer, H. Peter and Stark, Mitchell S. (2021). Circulating biomarkers for early stage non-small cell lung carcinoma detection: supplementation to low‐dose computed tomography. Frontiers in Oncology, 11 555331, 555331. doi: 10.3389/fonc.2021.555331
Fuiten, Allison M., Fankhauser, Reilly G., Smit, Darren J., Stark, Mitchell S., Enright, Trevor F., Wood, Mary A., DePatie, Nicholas A., Pivik, Karla, Sturm, Richard A., Berry, Elizabeth G. and Kulkarni, Rajan P. (2021). Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa. Pigment Cell & Melanoma Research, 34 (6) pcmr.12979, 1123-1130. doi: 10.1111/pcmr.12979
Stark, Mitchell S., Tell-Martí, Gemma, Martins da Silva, Vanessa, Martinez-Barrios, Estefania, Calbet-Llopart, Neus, Vicente, Asunción, Sturm, Richard A., Soyer, H. Peter, Puig, Susana, Malvehy, Josep, Carrera, Cristina and Puig-Butillé, Joan A. (2021). The distinctive genomic landscape of giant congenital melanocytic nevi. Journal of Investigative Dermatology, 141 (3), 692-695. doi: 10.1016/j.jid.2020.07.022
Lee, Katie J., Janda, Monika, Stark, Mitchell S, Sturm, Richard A. and Soyer, H. Peter (2021). On naevi and melanomas: two sides of the same coin?. Frontiers in Medicine, 8 635316, 635316. doi: 10.3389/fmed.2021.635316
Emmett, S.E., Stark, M.S., Pandeya, N., Panizza, B., Whiteman, D.C. and Antonsson, A. (2021). MicroRNA expression is associated with human papillomavirus status and prognosis in mucosal head and neck squamous cell carcinomas. Oral Oncology, 113 105136, 105136. doi: 10.1016/j.oraloncology.2020.105136
McMeniman, E. K., McInerney-Leo, A. M., Peach, E., Lee, K. J., Yanes, T., Jagirdar, K., Stark, M. S., Soyer, H. P., Duffy, D. L. and Sturm, R. A. (2020). CDKN2A testing threshold in a high-risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk. Journal of the European Academy of Dermatology and Venereology, 34 (12) jdv.16627, e797-e798. doi: 10.1111/jdv.16627
Stark, Mitchell S., Denisova, Evgeniya, Kays, Trent A., Heidenreich, Barbara, Rachakonda, Sivaramakrishna, Requena, Celia, Sturm, Richard A., Soyer, H. Peter, Nagore, Eduardo and Kumar, Rajiv (2020). Mutation signatures in melanocytic nevi reveal characteristics of defective DNA repair. Journal of Investigative Dermatology, 140 (10), 2093-2096.e2. doi: 10.1016/j.jid.2020.02.021
Rayner, Jenna E., Duffy, David L., Smit, Darren J., Jagirdar, Kasturee, Lee, Katie J., De’Ambrosis, Brian, Smithers, B. Mark, McMeniman, Erin K., McInerney-Leo, Aideen M., Schaider, Helmut, Stark, Mitchell S., Soyer, H. Peter and Sturm, Richard A. (2020). Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants. PLoS ONE, 15 (9) e0238529, e0238529. doi: 10.1371/journal.pone.0238529
Grossman, Douglas, Okwundu, Nwanneka, Bartlett, Edmund K., Marchetti, Michael A., Othus, Megan, Coit, Daniel G., Hartman, Rebecca I., Leachman, Sancy A., Berry, Elizabeth G., Korde, Larissa, Lee, Sandra J., Bar-Eli, Menashe, Berwick, Marianne, Bowles, Tawnya, Buchbinder, Elizabeth I., Burton, Elizabeth M., Chu, Emily Y., Curiel-Lewandrowski, Clara, Curtis, Julia A., Daud, Adil, Deacon, Dekker C., Ferris, Laura K., Gershenwald, Jeffrey E., Grossmann, Kenneth F., Hu-Lieskovan, Siwen, Hyngstrom, John, Jeter, Joanne M., Judson-Torres, Robert L., Kendra, Kari L. ... Swetter, Susan M. (2020). Prognostic Gene Expression Profiling in Cutaneous Melanoma : Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatology, 156 (9), e1-e8. doi: 10.1001/jamadermatol.2020.1729
Roy, Edwige, Wong, Ho Yi, Villani, Rehan, Rouille, Thomas, Salik, Basit, Sim, Seen Ling, Murigneux, Valentine, Stark, Mitchell S., Fink, J. Lynn, Soyer, H. Peter, Walker, Graeme, Lyons, J. Guy, Saunders, Nicholas and Khosrotehrani, Kiarash (2020). Regional Variation in Epidermal Susceptibility to UV-Induced Carcinogenesis Reflects Proliferative Activity of Epidermal Progenitors. Cell Reports, 31 (9) 107702, 107702. doi: 10.1016/j.celrep.2020.107702
Pavey, Sandra, Pinder, Alex, Fernando, Winnie, D'Arcy, Nicholas, Matigian, Nicholas, Skalamera, Dubravka, Lê Cao, Kim-Anh, Loo-Oey, Dorothy, Hill, Michelle M., Stark, Mitchell, Kimlin, Michael, Burgess, Andrew, Cloonan, Nicole, Sturm, Richard A. and Gabrielli, Brian (2019). Multiple interaction nodes define the post-replication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation load. Molecular Oncology, 14 (1) 1878-0261.12601, 22-41. doi: 10.1002/1878-0261.12601
Stark, Mitchell S., Gray, Elin S., Isaacs, Timothy, Chen, Fred K., Millward, Michael, McEvoy, Ashleigh, Zaenker, Pauline, Ziman, Melanie, Soyer, H. Peter, Glasson, William J., Warrier, Sunil K., Stark, Andrew L., Rolfe, Olivia J., Palmer, Jane M. and Hayward, Nicholas K. (2019). A panel of circulating microRNAs detects uveal melanoma with high precision. Translational Vision Science and Technology, 8 (6) 12, 12-12. doi: 10.1167/tvst.8.6.12
Duffy, D. L., Lee, K. J., Jagirdar, K., Pflugfelder, A., Stark, M. S., McMeniman, E. K., Soyer, H. P. and Sturm, R. A. (2019). Naevus count and MC1R R alleles contribute to melanoma risk. British Journal of Dermatology, 181 (5), e119-e119. doi: 10.1111/bjd.18487
Stark, Mitchell S. (2019). Large-giant congenital melanocytic nevi: moving beyond NRAS mutations. Journal of Investigative Dermatology, 139 (4), 756-759. doi: 10.1016/j.jid.2018.10.003
Duffy, D. L., Lee, K. J., Jagirdar, K., Pflugfelder, A., Stark, M. S., McMeniman, E. K., Soyer, H. P. and Sturm, R. A. (2019). High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk. British Journal of Dermatology, 181 (5) bjd.17833, 1009-1016. doi: 10.1111/bjd.17833
Tan, Jean-Marie, Tom, Lisa N., Soyer, H. Peter and Stark, Mitchell S. (2018). Defining the molecular genetics of dermoscopic naevus patterns. Dermatology , 235 (1), 1-16. doi: 10.1159/000493892
Hendricks, William P D, Zismann, Victoria, Sivaprakasam, Karthigayini, Legendre, Christophe, Poorman, Kelsey, Tembe, Waibhav, Perdigones, Nieves, Kiefer, Jeffrey, Liang, Winnie, DeLuca, Valerie, Stark, Mitchell, Ruhe, Alison, Froman, Roe, Duesbery, Nicholas S, Washington, Megan, Aldrich, Jessica, Neff, Mark W, Huentelman, Matthew J, Hayward, Nicholas, Brown, Kevin, Thamm, Douglas, Post, Gerald, Khanna, Chand, Davis, Barbara, Breen, Matthew, Sekulic, Alexander and Trent, Jeffrey M (2018). Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis. PLoS Genetics, 14 (9) e1007589, e1007589. doi: 10.1371/journal.pgen.1007589
Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms (vol 138, pg 1636, 2018). Journal of Investigative Dermatology, 138 (9), 2085-2085. doi: 10.1016/j.jid.2018.06.174
Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms. Journal of Investigative Dermatology, 138 (7), 1636-1644. doi: 10.1016/j.jid.2018.02.012
Tan, J. M., Tom, L. N., Jagirdar, K., Lambie, D., Schaider, H., Sturm, R. A., Soyer, H. P. and Stark, M. S. (2018). The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation. British Journal of Dermatology, 178 (1), 191-197. doi: 10.1111/bjd.15809
Emran, Abdullah Al, Marzese, Diego M., Menon, Dinoop Ravindran, Stark, Mitchell S., Torrano, Joachim, Hammerlindl, Heinz, Zhang, Gao, Brafford, Patricia, Salomon, Matthew P., Nelson, Nellie, Hammerlindl, Sabrina, Gupta, Deepesh, Mills, Gordon B., Lu, Yiling, Sturm, Richard A., Flaherty, Keith, Hoon, Dave S. B., Gabrielli, Brian, Herlyn, Meenhard and Schaider, Helmut (2017). Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget, 9 (9), 8206-8222. doi: 10.18632/oncotarget.23654
Stark, Mitchell S. (2017). Melanoma treatment guided by a panel of microRNA biomarkers. Melanoma Management, 4 (2), 71-74. doi: 10.2217/mmt-2017-0006
Stark, Mitchell S., Tom, Lisa N., Boyle, Glen M., Bonazzi, Vanessa F., Soyer, H. Peter, Herington, Adrian C., Pollock, Pamela M. and Hayward, Nicholas K. (2016). The 'Melanoma-enriched' microRNA miR-4731-5p acts as a tumour suppressor. Oncotarget, 7 (31), 49677-49687. doi: 10.18632/oncotarget.10109
Stark, Mitchell S., Bonazzi, Vanessa F., Boyle, Glen M., Palmer, Jane M., Symmons, Judith, Lanagan, Catherine M., Schmidt, Christopher W., Herington, Adrian C., Ballotti, Robert, Pollock, Pamela M. and Hayward, Nicholas K. (2015). miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma. Oncotarget, 6 (19), 17753-17763. doi: 10.18632/oncotarget.3924
Tembe, Varsha, Schramm, Sarah-Jane, Stark, Mitchell, Patrick, Ellis, Jayaswal, Vivek, Tang, Yue Hang, Barbour, Andrew, Hayward, Nicholas K., Thompson, John F., Scolyer, Richard A., Yang, Yee Hwa and Mann, Graham J. (2015). MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis. Pigment Cell and Melanoma Research, 28 (3), 254-266. doi: 10.1111/pcmr.12343
Stark, Mitchell S., Klein, Kerenaftali, Weide, Benjamin, Haydu, Lauren E., Pflugfelder, Annette, Tang, Yue Hang, Palmer, Jane M., Whiteman, David C., Scolyer, Richard A., Mann, Graham J., Thompson, John F., Long, Georgina V., Barbour, Andrew P., Soyer, H. Peter, Garbe, Claus, Herington, Adrian, Pollock, Pamela M. and Hayward, Nicholas K. (2015). The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis. EBioMedicine, 2 (7), 671-680. doi: 10.1016/j.ebiom.2015.05.011
Aoude, Lauren G., Pritchard, Antonia L., Robles-Espinoza, Carla Daniela, Wadt, Karin, Harland, Mark, Choi, Jiyeon, Gartside, Michael, Quesada, Victor, Johansson, Peter, Palmer, Jane M., Ramsay, Andrew J., Zhang, Xijun, Jones, Kristine, Symmons, Judith, Holland, Elizabeth A., Schmid, Helen, Bonazzi, Vanessa, Woods, Susan, Dutton-Regester, Ken, Stark, Mitchell S., Snowden, Helen, van Doom, Remco, Montgomery, Grant W., Martin, Nicholas G., Keane, Thomas M., Lopez-Otin, Carlos, Gerdes, Anne-Marie, Olsson, Hakan, Ingvar, Christian ... Hayward, Nicholas K. (2015). Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. Journal of the National Cancer Institute, 107 (2) dju408, 1-7. doi: 10.1093/jnci/dju408
Stark, Mitchell S. (2014). miRNAs: back seat drivers no more. Pigment Cell & Melanoma Research, 27 (4), 510-511. doi: 10.1111/pcmr.12247
Robles-Espinoza, Carla Daniela, Harland, Mark, Ramsay, Andrew J, Aoude, Lauren G, Quesada, Víctor, Ding, Zhihao, Pooley, Karen A, Pritchard, Antonia L, Tiffen, Jessamy C, Petljak, Mia, Palmer, Jane M, Symmons, Judith, Johansson, Peter, Stark, Mitchell S., Gartside, Michael G, Snowden, Helen, Montgomery, Grant W, Martin, Nicholas G, Liu, Jimmy Z, Choi, Jiyeon, Makowski, Matthew, Brown, Kevin M, Dunning, Alison M, Keane, Thomas M, Lopez-Otin, Carlos, Gruis, Nelleke A, Hayward, Nicholas K, Bishop, D Timothy, Newton-Bishop, Julia A and Adams, David J (2014). POT1 loss-of-function variants predispose to familial melanoma. Nature Genetics, 46 (5), 478-481. doi: 10.1038/ng.2947
Dutton-Regester, K., Kakavand, H., Aoude, L.G., Stark, M.S., Gartside, M.G., Johansson, P., O'Connor, L., Lanagan, C., Tembe, V., Pupo, G.M., Haydu, L.E., Schmidt, C.W., Mann, G.J., Thompson, J.F., Scolyer, R.A. and Hayward, N.K. (2013). Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. Pigment Cell and Melanoma Research, 26 (6), 852-860. doi: 10.1111/pcmr.12153
Mould, Arne W., Pang, Zhenyi, Pakusch, Miha, Tonks, Ian D., Stark, Mitchell, Carrie, Dianne, Mukhopadhyay, Pamela, Seidel, Annica, Ellis, Jonathan J., Deakin, Janine, Wakefield, Matthew J., Krause, Lutz, Blewitt, Marnie E. and Kay, Graham F. (2013). Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation. Epigenetics and Chromatin, 6 (19) 19, 1-16. doi: 10.1186/1756-8935-6-19
Brooks, Kelly, Chia, Kee Ming, Spoerri, Loredana, Mukhopadhyay, Pamela, Wigan, Matthew, Stark, Mitchell, Pavey, Sandra and Gabrielli, Brian (2013). Defective decatenation checkpoint function is a common feature of melanoma. Journal of Investigative Dermatology, 134 (1), 150-158. doi: 10.1038/jid.2013.264
Dutton-Regester, Ken, Aoude, Lauren G., Nancarrow, Derek J., Stark, Mitchell S., O'Connor, Linda, Lanagan, Cathy, Pupo, Gulietta M., Tembe, Varsha, Carter, Candace D., O'Rourke, Michael, Scolyer, Richard A., Mann, Graham J., Schmidt, Christopher W., Herington, Adrian and Hayward, Nicholas K. (2012). Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene. Genes Chromosomes and Cancer, 51 (5), 452-461. doi: 10.1002/gcc.21932
Bonazzi, Vanessa F., Stark, Mitchell S. and Hayward, Nicholas K. (2012). MicroRNA regulation of melanoma progression. Melanoma Research, 22 (2), 101-113. doi: 10.1097/CMR.0b013e32834f6fbb
Stark, Mitchell S., Woods, Susan L., Gartside, Michael G., Bonazzi, Vanessa F., Dutton-Regester, Ken, Aoude, Lauren G., Chow, Donald, Sereduk, Chris, Niemi, Natalie M., Tang, Nanyun, Ellis, Jonathan J., Reid, Jeffrey, Zismann, Victoria, Tyagi, Sonika, Muzny, Donna, Newsham, Irene, Wu, YuanQing, Palmer, Jane M., Pollak, Thomas, Youngkin, David, Brooks, Bradford R., Lanagan, Catherine, Schmidt, Christopher W., Kobe, Bostjan, MacKeigan, Jeffrey P., Yin, Hongwei, Brown, Kevin M., Gibbs, Richard, Trent, Jeffrey and Hayward, Nicholas K. (2012). Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nature Genetics, 44 (2), 165-169. doi: 10.1038/ng.1041
Yokoyama, Satoru, Woods, Susan L., Boyle, Glen M., Aoude, Lauren G., MacGregor, Stuart, Zismann, Victoria, Gartside, Michael, Cust, Anne E., Haq, Rizwan, Harland, Mark, Taylor, John C., Duffy, David L., Holohan, Kelly, Dutton-Regester, Ken, Palmer, Jane M., Bonazzi, Vanessa, Stark, Mitchell S., Symmons, Judith, Law, Matthew H., Schmidt, Christopher, Lanagan, Cathy, O'Connor, Linda, Holland, Elizabeth A., Schmid, Helen, Maskiell, Judith A., Jetann, Jodie, Ferguson, Megan, Jenkins, Mark A., Kefford, Richard F. ... Brown, Kevin M. (2011). A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature, 480 (7375), 99-103. doi: 10.1038/nature10630
MacGregor, Stuart, Montgomery, Grant W., Liu, Jimmy Z., Zhao, Zhen Zhen, Henders, Anjali K., Stark, Mitchell, Schmid, Helen, Holland, Elizabeth A., Duffy, David L., Zhang, Mingfeng, Painter, Jodie N., Nyholt, Dale R., Maskiell, Judith A., Jetann, Jodie, Ferguson, Megan, Cust, Anne E., Jenkins, Mark A., Whiteman, David C., Olsson, Hakan, Puig, Susana, Bianchi-Scarra, Giovanna, Hansson, Johan, Demenais, Florence, Landi, Maria Teresa, Debniak, Tadeusz, Mackie, Rona, Azizi, Esther, Bressac-de Paillerets, Brigitte, Goldstein, Alisa M. ... Hayward, Nicholas K. (2011). Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nature Genetics, 43 (11), 1114-1118. doi: 10.1038/ng.958
Bonazzi, Vanessa F., Nancarrow, Derek J., Stark, Mitchell S., Moser, Ralf J., Boyle, Glen M., Aoude, Lauren G., Schmidt, Christopher and Hayward, Nicholas K. (2011). Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One, 6 (10) e26121, 1-9. doi: 10.1371/journal.pone.0026121
Boyle, Glen M., Woods, Susan L., Bonazzi, Vanessa F., Stark, Mitchell S., Hacker, Elke, Aoude, Lauren G., Dutton-Regester, Ken, Cook, Anthony L., Sturm, Richard A. and Hayward, Nicholas K. (2011). Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell and Melanoma Research, 24 (3), 525-537. doi: 10.1111/j.1755-148X.2011.00849.x
Tyagi, Sonika, Stark, Mitchell S., Hayward, Nicholas K., Whiteman, David C. and Nancarrow, Derek J. (2010). WebFOG: A web tool to map genomic features onto genes. Biochemical and Biophysical Research Communications, 401 (3), 447-450. doi: 10.1016/j.bbrc.2010.09.077
Demenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton Bishop, J. A., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E., Elder, D. E., Avril, M. F., Azizi, E., van Belle, P., Bergman, W., Bianchi-Scarra, G., Brassac-de Paillerets, B., Calista, D., Carrera, C., Hansson, J., Harland, M., Hogg, D., Hoiom, V., Holland, E. A., Ingvar, C., Landi, M. T., Lang, J. M., Mackie, R. M., Mann, G. J., Ming, M. E. ... Melanoma Genetics Consortium (2010). Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: A GenoMEL study. Journal of the National Cancer Institute, 102 (20), 1568-1583. doi: 10.1093/jnci/djq363
Whiteman, D.C., Parmar, P., Fahey, P., Moore, S.P., Stark, M., Zhao, Z.Z., Montgomery, G.W., Green, A.C., Hayward, N.K., Webb, P.M., Australian Cancer Study and Aoude, Lauren (2010). Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology, 139 (1), 73-83. doi: 10.1053/j.gastro.2010.04.009
Dry, Jonathan R., Pavey, Sandra, Pratilas, Christine A., Harbron, Chris, Runswick, Sarah, Hodgson, Darren, Chresta, Christine, McCormack, Rose, Byrne, Natalie, Cockerill, Mark, Graham, Alexander, Beran, Garry, Cassidy, Andrew, Haggerty, Carolyn, Brown, Helen, Ellison, Gillian, Dering, Judy, Taylor, Barry S., Stark, Mitchell, Bonazzi, Vanessa, Ravishankar, Sugandha, Packer, Leisl, Xing, Feng, Solit, David B., Finn, Richard S., Rosen, Neal, Hayward, Nicholas K., French, Tim and Smith, Paul D. (2010). Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244). Cancer Research, 70 (6), 2264-2273. doi: 10.1158/0008-5472.CAN-09-1577
Stark, Mitchell S., Tyagi, Sonika, Nancarrow, Derek J., Boyle, Glen M., Cook, Anthony L., Whiteman, David C., Parsons, Peter G., Schmidt, Christopher, Sturm, Richard A. and Hayward, Nicholas K. (2010). Characterization of the melanoma miRNAome by deep sequencing. PLoS One, 5 (3) e9685, e9685-1-e9685-9. doi: 10.1371/journal.pone.0009685
Bloethner, Sandra, Mould, Arne, Stark, Mitchell and Hayward, Nicholas K. (2008). Identification of ARHGEF17, DENND2D, FGFR3, and RBI mutations in melanoma by inhibition of nonsense-mediated mRNA decay. Genes, Chromosomes and Cancer, 47 (12), 1076-1085. doi: 10.1002/gcc.20598
Doecke, James, Zhao, Zhen Zhen, Pandeya, Nirmala, Sadeghi, Shahram, Stark, Mitchell, Green, Adele C., Hayward, Nicholas K., Webb, Penlope M. and Whiteman, David C. (2008). Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. International Journal of Cancer, 123 (1), 174-180. doi: 10.1002/ijc.23410
Brown, K. M., MacGregor, S., Montgomery, G. W., Craig, D. W., Zhao, Z. Z., Iyadurai, K., Henders, A. K., Homer, N., Campbell, M. J., Stark, M., Thomas, S., Schmid, H., Maskiell, J. A., Jetann, J., Ferguson, M., Stephan, D. A., Cust, A. E., Whiteman, D. C., Green, A., Olsson, H., Puig, S., Ghiorzo, P., Hansson, J., Demenais, F., Goldstein, A. M., Gruis, N. A., Elder, D. E., Newton Bishop, J., Kefford, R. F. ... Hayward, N. (2008). Common sequence variants on 20q11.22 confer melanoma susceptibility. Nature Genetics, 40 (7), 838-840. doi: 10.1038/ng.163
Harland, Mark, Goldstein, Alisa M., Kukalizch, Kairen, Taylor, Claire, Hogg, David, Puig, Susana, Badenas, Celia, Gruis, Nelleke, ter Huurne, Jeanet, Bergman, Wilma, Hayward, Nicholas K., Stark, Mitchell, Tsao, Hensin, Tucker, Margret A., Landi, Maria Teresa, Scarra, Giovanna B., Ghiorzo, Paola, Kanetsky, Peter A., Elder, David, Mann, Graham J., Holland, Elizabeth A., Bishop, D. Timothy and Newton Bishop, Julia (2008). A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). European Journal of Cancer, 44 (9), 1269-1274. doi: 10.1016/j.ejca.2008.03.005
Sturm, Richard A., Duffy, David L., Zhao, Zhen Zhen, Leite, Fabio P.N., Stark, Mitchell S., Hayward, Nicholas K., Martin, Nicholas G. and Montgomery, Grant W. (2008). A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye colour. The American Journal of Human Genetics, 82 (2), 424-431. doi: 10.1016/j.ajhg.2007.11.005
Doecke, J D, Zhao, Z Z, Stark, M S, Green, A C, Hayward, N K, Montgomery, G W, Webb, P M and Whiteman, D C (2008). Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers. Cancer Epidemiology, Biomarkers & Prevention, 17 (4), 1007-1012. doi: 10.1158/1055-9965.EPI-08-0023
Nancarrow, Derek J., Handoko, Herlina Y., Stark, Mitchell S., Whiteman, David C. and Hayward, Nicholas K. (2007). SiDCoN: A tool to aide scoring of DNA copy number changes in SNP chip data. PLoS One, 2 (10) e1093, e1093. doi: 10.1371/journal.pone.0001093
Packer, Leisl M., Pavey, Sandra J., Boyle, Glen M., Stark, Mitchell S., Ayub, Ana L., Rizos, Helen and Hayward, Nicholas K. (2007). Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF. International Journal of Cancer, 121 (4), 784-790. doi: 10.1002/ijc.22725
Pujana, M. A., Ruiz, A., Badenas, C., Puig-Butille, J-A., Nadal, M., Stark, M., Gomez, L., Valls, J., Sole, X., Hernandez, P., Cerrato, C., Madrigal, I., de Cid, R., Aguilar, H., Capella, G., Cal, S., James, M. R., Walker, G. J., Malvehy, J., Mila, M., Hayward, N. K., Estivill, X. and Puig, S. (2007). Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Genes, Chromosomes & Cancer, 46 (2), 155-162. doi: 10.1002/gcc.20396
Loffler, Kelly A., Biondi, Christine A., Gartside, Michael, Waring, Paul, Stark, Mitchell, Serewko-Auret, Magdalena M., Muller, H. Konrad, Hayward, Nicholas K. and Kay, Graham F. (2007). Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. International Journal of Cancer, 120 (2), 259-267. doi: 10.1002/ijc.22288
Lang, J, Hayward, N, Goldgar, D, Tsao, H, Hogg, D, Palmer, J, Stark, M, Tobias, ES and MacKie, R (2007). The M531 mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry. Genes Chromosomes & Cancer, 46 (3), 277-287. doi: 10.1002/gcc.20410
Stark, M. and Hayward, N. (2007). Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-denisty single-nucleotide polymorphism arrays. Cancer Research, 67 (6), 2632-2642. doi: 10.1158/0008-5472.CAN-06-4152
Goldstein, Alisa M., Chan, May, Harland, Mark, Hayward, Nicholas K., Demenais, Florence, Bishop, D. Timothy, Azizi, Esther, Bergman, Wilma, Bianchi-Scarra, Giovanna, Bruno, William, Calista, Donato, Cannon Albright, Lisa A., Chaudru, Valerie, Chompret, Agnes, Cuellar, Francisco, Elder, David E., Ghiorzo, Paola, Gillanders, Elizabeth M., Gruis, Nelleke A., Hansson, Johan, Hogg, David, Holland, Elizabeth A., Kanetsky, Peter A., Kefford, Richard F., Landi, Maria T., Lang, Julie, Leachman, Sancy A., MacKie, Rona M., Magnusson, Veronica ... Eliason, Mark (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. Journal of Medical Genetics, 44 (2), 99-106. doi: 10.1136/jmg.2006.043802
Goldstein, Alisa M., Chan, May, Harland, Mark, Gillanders, Elizabeth M., Hayward, Nicholas K., Avril, Marie-Francoise, Azizi, Esther, Bianchi-Scarra, Giovanna, Bishop, D. Timothy, Bressac-de Paillerets, Brigitte, Bruno, William, Calista, Donato, Cannon Albright, Lisa A., Demenais, Florence, Elder, David E., Ghiorzo, Paola, Gruis, Nelleke A., Hansson, Johan, Hogg, David, Holland, Elizabeth A., Kanetsky, Peter A., Kefford, Richard F., Landi, Maria Teresa, Lang, Julie, Leachman, Sancy A., MacKie, Rona M., Magnusson, Veronica, Mann, Graham J., Niendorf, Kristin ... Melanoma Genetics Consortium (GenoMEL) (2006). High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL. Cancer research, 66 (20), 9818-9828. doi: 10.1158/0008-5472.CAN-06-0494
Packer, Leisl, Pavey, Sandra, Parker, Andrew, Stark, Mitchell, Johansson, Peter, Clarke, Belinda, Pollock, Pamela, Ringner, Markus and Hayward, Nicholas (2006). Osteopontin is a Downstream Effector of the PI3-kinase Pathway in Melanomas that is Inversely Correlated with Functional PTEN. Carcinogenesis, 27 (9), 1778-1786. doi: 10.1093/carcin/bgl016
Curtin, John A., Stark, Mitchell S., Pinkel, Daniel, Hayward, Nicholas K. and Bastian, Boris C. (2006). PI3-Kinase Subunits Are Infrequent Somatic Targets in Melanoma. Journal of Investigative Dermatology, 126 (7), 1660-1663. doi: 10.1038/sj.jid.5700311
Stark, M., Puig-Butille, J. A., Walker, G., Badenas, C., Malvehy, J., Hayward , N. and Puig, S. (2006). Mutation of the tumour suppressor p33ING1b is rare in melanoma. British Journal of Dermatology, 155 (1), 94-99. doi: 10.1111/j.1365-2133.2006.07274.x
James, Michael R., Dumeni, Troy, Stark, Mitchell S., Duffy, David L., Montgomery, Grant W., Martin, Nicholas G. and Hayward, Nicholas K. (2006). Rapid screening of 4000 individuals for germ-line variations in the BRAF gene. Clinical Chemistry, 52 (9), 1675-1678. doi: 10.1373/clinchem.2006.070169
James, Michael R., Roth, Richard B., Shi, Michael M., Kammerer, Stefan, Nelson, Matthew R., Stark, Mitchell S., Dumenil, Troy, Montgomery, Grant W., Hayward, Nicholas K., Martin, Nicholas G., Braun, Andreas and Duffy, David L. (2005). BRAF Polymorphisms and Risk of Melanocytic Neoplasia. Journal of Investigative Dermatology, 125 (6), 1252-1258. doi: 10.1111/j.0022-202X.2005.23937.x
Zuidervaart, W., van Nieuwpoort, F., Stark, M., Dijkman, R., Packer, L., Borgstein, A. -M., Pavey, S., van der Velden, P., Out, C., Jager, M. J., Hayward, N. K. and Gruis, N. A. (2005). Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. British Journal of Cancer, 92 (11), 2032-2038. doi: 10.1038/sj.bjc.6602598
Pavey, Sandra, Johansson, Peter, Packer, Leisl, Taylor, Jennifer, Stark, Mitchell, Pollock, Pamela M., Walker, Graeme J., Boyle, Glen M., Harper, Ursula, Cozzi, Sarah-Jane, Hansen, Katherine, Yudt, Laura, Schmidt, Chris, Hersey, Peter, Ellem, Kay A. O., O'Rourke, Michael G. E., Parsons, Peter G., Meltzer, Paul, Ringnér, Markus and Hayward, Nicholas K. (2004). Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene, 23 (23), 4060-4067. doi: 10.1038/sj.onc.1207563
Biondi, C. A., Gartside, M. G., Waring, P., Loffler, K. A., Stark, M. S., Magnuson, M. A., Kay, G. F. and Hayward, N. K. (2004). Conditional inactivation of the Men1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Molecular And Cellular Biology, 24 (8), 3125-3131. doi: 10.1128/MCB.24.8.3125-3131.2004
Vajdic, C, Kricker, A, Duffy, DL, Aitken, JF, Stark, M, ter Huurne, JAC, Martin, NG, Armstrong, BK and Hayward, NK (2003). Ocular melanoma is not associated with CDKN2A or MC1R variants - a population-based study. Melanoma Research, 13 (4), 409-413. doi: 10.1097/01.cmr.0000056244.56735.28
Gillanders, Elizabeth, Juo, Suh-Hang Hank, Holland, Elizabeth A., Jones, MaryPat, Nancarrow, Derek, Freas-Lutz, Diana, Sood, Raman, Park, Naeun, Faruque, Mezbah, Markey, Carol, Kefford, Richard F., Palmer, Jane, Bergman, Wilma, Bishop, D. Timothy, Tucker, Margaret A., Bressac-de Paillerets, Brigitte, Hansson, Johan, The Lund Melanoma Study Group, Stark, Mitchell, Gruis, Nelleke, Newton Bishop, Julia, Goldstein, Alisa M., Bailey-Wilson, Joan E., Mann, Graham J., Hayward, Nicholas, Trent, Jeffrey, Martin, Nicholas G. and The Melanoma Genetics Consortium (2003). Localization of a novel melanoma susceptibility locus to 1p22. American Journal of Human Genetics, 73 (2), 301-313. doi: 10.1086/377140
Pollock, Pamela M., Harper, Ursula L., Hansen, Katherine S., Yudt, Laura M., Stark, Mitchell, Robbins, Christiane M., Moses, Tracy Y., Hostetter, Galen, Wagner, Urs, Kakareka, John, Salem, Ghadi, Pohida, Tom, Heenan, Peter, Duray, Paul, Kallioniemi, Olli, Hayward, Nicholas K., Trent, Jeffrey M. and Meltzer, Paul S. (2003). High frequency of BRAF mutations in nevi. Nature Genetics, 33 (1), 19-20. doi: 10.1038/ng1054
Pollock, Pamela M., Stark, Mitchell S., Palmer, Jane M., Walters, Marilyn K., Aitken, Joanne F., Martin, Nicholas G. and Hayward, Nicholas K. (2001). Mutation analysis of the CDKN2A promoter in Australian melanoma families. Genes Chromosomes and Cancer, 32 (1), 89-94. doi: 10.1002/gcc.1170
Welch, John, Millar, Doug, Goldman, Alana, Heenan, Peter, Stark, Mitchell, Eldon, Michael, Clark, Susan, Martin, Nicholas G. and Hayward, Nicholas K. (2001). Lack of Genetic and Epigenetic Changes in CDKN2A in Melanocytic Nevi [Letter to the editor]. Journal of Investigative Dermatology, 117 (2), 383-384. doi: 10.1046/j.0022-202x.2001.01391.x
Box, N. F., Duffy, D. L., Chen, W., Stark, M., Martin, N. G., Sturm, R. A. and Hayward, N. K. (2001). MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. American Journal of Human Genetics, 69 (4), 765-773. doi: 10.1086/323412
Conference Papers
Harris, Teresa, Zaenker, Pauline, McEvoy, Ashleigh C., Soyer, H. Peter, Khattak, Muhammad A., Ziman, Melanie, Millward, Michael, Gray, Elin S. and Stark, Mitchell S. (2024). Assessment of precision melanoma diagnostics: Circulating microrna expression to monitor late-stage treatment. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-7626
Zhou, C., Tan, S. X., Kao, Y., Claeson, M., Brown, S., Lambie, D., Whiteman, D., Soyer, H., Stark, M., Nguyen, Q. and Khosrotehrani, K. (2023). 275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.279
Betz-Stablein, B. D., Rutjes, C., Kahler, S., Mothershaw, A., Jayasinghe, D., Stark, M., Janda, M. and Soyer, H. (2023). 203 Automated skin surface phenotype for melanoma risk assessment. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.205
Kahler, Sam, Rutjes, Chantal, Yan, Siyuan, Mothershaw, Adam, Yu, Zhen, Jayasinghe, Dilki, Ge, Zongyuan, Stark, Mitchell, Janda, Monika, Soyer, Peter and Betz-Stablein, Brigid (2023). Automated photodamage assessment from 3D total body photography for an objective assessment of melanoma risk. Australasian College of Dermatologists 55th Annual Scientific Meeting, Engage, Enhance, Elevate, Virtual, 27-29 May 2023. Richmond, VIC Australia: John Wiley & Sons.
Muse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. 114th Annual Meeting of the American Association for Cancer Research (AACR), Orlando Fl, Apr 14-19, 2023. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2023-6000
Kan, C., Crovetto, N., Landreneau, R., Li, L., Soyer, H., Stark, M. S. and Gunn, S. (2020). Identification of a novel microrna panel: potential biomarkers for non-small cell lung cancer. Southern Regional Meeting of the American-Federation-for-Medical-Research (AFMR), New Orleans, LA, United States, 13-15 February 2020. London, United Kingdom: B M J Group. doi: 10.1136/jim-2020-SRM.565
Emran, A., Marzese, D. M., Menon, D. R., Stark, M., Torrano, J., Hammerlindl, H., Zhang, G., Brafford, P., Hammerlindl, S., Gupta, D., Mills, G. B., Lu, Y., Flaherty, K., Sturm, R., Hoon, D. S. B., Gabrielli, B., Herlyn, M. and Schaider, H. (2018). Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia , 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.16_12815
Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, Illinois, 14-18 April 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2018-5376
Tan, J-M., Tom, L., Jagirdar, K., Lambie, D., Sturm, R., Soyer, P. and Stark, M. (2017). The prevalence of BRAF and NRAS in dermoscopic subtypes of acquired naevi. Australasian College of Dermatologists 50th Annual Scientific Meeting, Darling Harbour, New South Wales, Australia, 6–9 May 2017. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.21_12652
Stark, M., Gray, E., Ziman, M., Soyer, H. P. and Schaider, H. (2016). Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?. 16th World Congress on Cancers of the Skin , Vienna, Austria, 31 August - 3 September 2016. Philadelphia, PA United States: Lippincott Williams & Wilkins.
Emran, A. A., Menon, D. R., Marzese, D., Hammerlindl, H., Brafford, P., Stark, M., Huang, S., Hammerlindl, S., Gupta, D., Soyer, P., Sturm, R., Hoon, D., Gabrielli, B., Herlyn, M. and Schaider, H. (2016). Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancer. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell.
Ahmed, F., Tonnessen, C., Spoerri, L., Daignault, S., Stark, M., Schaider, H., Hill, M. and Haass, N. (2016). Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12584
Wright, C. M., Francis, S. M. Savarimuthu, Sriram, K. B., Stark, M. S., Hayward, N. K., Yang, I. A., Bowman, R. V. and Fong, K. M. (2013). Distinct profiles for lung cancer and its major subtypes. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12045
Wright, C. M., Francis, S. M. S., Sriram, K. B., Quinn, K. R., Stark, M. S., Hayward, N. K., Yang, I. A., Bowman, R. V. and Fong, K. M. (2011). Mapping the lung cancer methylome. 3rd Australian Lung Cancer Conference (ALCC), Melbourne VIC, Australia, 6-9 October 2010. Philadelphia PA, United States: Lippincott Williams & Wilkins.
Pollock, Pamela. M., Stark, Mitchell, Palmer, Jane M., Walters, Marilyn K., Martin, Nick G., Green, Adele C. and Hayward, Nicholas K. (2001). Mutation analysis of the CDKN2A promoter in Australian melanoma families. Unknown, Unknown, Unknown. New York, NY, United States: Springer Nature. doi: 10.1038/87254